S econdary hyperparathyroidism, characterized by an increase in the synthesis and secretion of parathyroid hormone (PTH) and parathyroid hyperplasia, is a very common complication of chronic kidney disease. 1 Despite significant advances in medic c cal therapy, in 5% to 10% of patients with chronic renal failure, parathyroidectomy (PTX) may be indicated. 2, 3 Unfortunately, recurrent or persistent hyperparac c thyroidism can be seen in up to 10% of patients after PTX. 4, 5 Our case was a 44cyearcold women with recurc c rent hyperparathyroidism after total PTX with autoc c transplantation into the sternocleidomastoid muscle, who presented with an enlarged neck structure. She had chronic renal failure due to chronic glomerulonephritis and was on hemodialysis. Four years later, total PTX with autotransplantation in a single area into the sterc c nocleidomastoid muscle was performed. Seven years after the surgery, the intact PTH level was 2630 pg/mL (normal range, 6c62 pg/mL), and total alkaline phosc c phatase was 682 IU/L (normal range, 60c170 IU/L). The patient refused a new operation. Two years later an enlarged structure in the neck was observed (Figure 1) . At that time, intact PTH was 2632 pg/mL and total alkaline phosphatase was 818 IU/L. By ultrasound, five enlarged structures suspected of having hyperplastic parathyroid tissue were found; a small one (dimension 0.9×0.9×0.8 cm) with uniform echoes and four larger ones with a nodular pattern of hyperplasia. The largest one, with dimensions of 2.5×1.3×2.2 cm was detected subcutaneously and by palpation, corresponding to the nearby enlarged structure, the left sternocleidomasc c toid muscle. We assumed that the largest nodule was 
